treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk.
. at this, shehbaz reassured them that the interview was taken out of context. this is unedited, unformatted feed from the press trust of india wire.
.
.
cambridge's bluebird bio licenses delivery tech to novartis, gsk
.